This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Min Li, PhD
Director, Protein Science at Tallac Therapeutics


Dr. Min Li joined Tallac in Aug 2020 to lead Protein Science group and have been involved in various Tallac programs on protein engineering and antibody discovery. Previously, Dr. Li served as a group leader and senior principal scientist in Protein Science Group, Novartis Institutes of Biomedical Sciences at Emeryville, CA. Dr. Li has worked extensively in drug discovery projects across the oncology and infectious diseases field during her 12 year of tenure. She earned her Ph.D in Biochemistry with focus on enzymology from Emory University in 2005 and completed her postdoctoral training at UCSF from 2005 to 2008 with extensive work on membrane protein expression as part of NIH protein structure initiative.

Agenda Sessions

  • Toll-Like Receptor (TLR9) Agonist Antibody Conjugates For Targeted Immune Activation